LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,444 Cr | ₹1,193 Cr | ₹1,159 Cr | ₹1,179 Cr | ₹928 Cr |
What is the latest Total Non-Current Liabilities ratio of LAURUS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,444 Cr |
| Mar2025 | ₹1,193 Cr |
| Mar2024 | ₹1,159 Cr |
| Mar2023 | ₹1,179 Cr |
| Mar2022 | ₹928 Cr |
How is Total Non-Current Liabilities of LAURUS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,444 Cr | 21.04 | |
| Mar2025 | ₹1,193 Cr | 2.95 | |
| Mar2024 | ₹1,159 Cr | -1.72 | |
| Mar2023 | ₹1,179 Cr | 27.10 | |
| Mar2022 | ₹928 Cr | - | |
Compare Total Non-Current Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹75,873.8 Cr | 1.5% | 16.4% | 136.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 1.5% |
16.4% |
136.7% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses